Healthy Skepticism Library item: 8220

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Clear PR, Grobler M.
Regulating the pharmaceutical industry. Australian scheme has disadvantages.
BMJ 1998 Jan 17;
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2665411

Abstract:

The impact of Australia’s regulations requiring mandatory cost-effectiveness evaluation of new drugs by the pharmaceutical industry prior to marketing is discussed, including their effects on the availability of new agents, restrictions on prescribing choices, and reduced funding for research as a consequence of increased marketing costs.

Keywords:
Australia Cost-Benefit Analysis Drug Costs Drug Industry/economics* Great Britain Humans